Ketamine for Treatment-Resistant Depression: Who Is a Good Candidate?

Depression can feel relentless when nothing seems to work. You may have tried medication after medication, committed to therapy, adjusted your lifestyle, and still wake up with the same heavy weight pressing down on your chest. The exhaustion of hoping for change, only to feel disappointed again, can make the future seem painfully narrow.

If you are living with treatment-resistant depression, you are not alone. Many people reach a point where standard antidepressants bring little or no relief. The long wait for improvement, combined with ongoing symptoms, can affect your work, relationships, and sense of self. It can also make you question whether anything will truly help.

In recent years, ketamine for treatment resistant depression has emerged as a new and different option. Unlike traditional antidepressants that can take weeks to work, ketamine may ease symptoms within hours or days for some patients. That possibility alone offers hope to people who have spent years waiting for change.

At Lonerock Clinic in Glide, Oregon, whole-person care means looking beyond one-size-fits-all solutions. Ketamine therapy is not right for everyone, but for carefully selected individuals, it may provide meaningful relief when other treatments have failed. Understanding who is a good candidate is the first step in deciding whether to have this conversation with your clinician.

Understanding Treatment-Resistant Depression

Before deciding whether ketamine therapy makes sense, it is important to clarify what treatment-resistant depression (TRD) means.

What Is Treatment-Resistant Depression?

Treatment-resistant depression typically refers to major depressive disorder that has not improved after at least two adequate trials of antidepressant medications. “Adequate” means the medication was taken at the right dose and for a sufficient duration.

Clinicians also consider other factors before labeling depression as treatment-resistant. They review medication adherence, reassess the diagnosis, and rule out medical causes, substance use, or other psychiatric conditions such as bipolar disorder or post-traumatic stress disorder.

TRD is not a personal failure. It reflects the biological complexity of depression and the reality that traditional monoaminergic medications do not work for everyone.

The Impact of TRD on Daily Life

People living with TRD often experience longer illness duration, more severe symptoms, and higher risk of hospitalization. Persistent low mood, loss of interest, sleep disruption, and cognitive fog can interfere with employment and relationships.

Rates of suicidal thoughts are also higher among individuals with treatment-resistant depression. The urgency for faster, more effective treatments has driven research into new mechanisms, including glutamate-based therapies like ketamine.

How Ketamine for Treatment Resistant Depression Works

Ketamine works differently from traditional antidepressants. Instead of primarily targeting serotonin or norepinephrine, it acts on the brain’s glutamate system.

NMDA Receptor Blockade and Glutamate Surge

Ketamine blocks NMDA receptors in the brain. This action leads to a temporary increase in glutamate release, which stimulates AMPA receptors. The result is a rapid shift in neural signaling that may improve mood more quickly than conventional medications.

This mechanism helps explain why ketamine for treatment resistant depression can produce noticeable changes within hours in some patients.

Neuroplasticity and Synapse Growth

Beyond symptom relief, ketamine appears to promote neuroplasticity. Research suggests it increases levels of brain-derived neurotrophic factor (BDNF) and activates pathways such as mTORC1, which support the growth of new synaptic connections.

Depression is associated with reduced synaptic density in key mood-regulating regions like the prefrontal cortex. By promoting synapse formation, ketamine may help restore healthier neural networks.

Who Is a Good Candidate for Ketamine Therapy?

Not everyone with depression is an ideal candidate. Careful screening is essential for safety and effectiveness.

Adults With Confirmed Treatment-Resistant Depression

The most appropriate candidates are adults diagnosed with major depressive disorder who have failed to respond to at least two adequate antidepressant trials. Documentation of past treatments helps determine eligibility.

Individuals who continue to experience moderate to severe symptoms despite psychotherapy and medication adjustments may also be considered.

Patients Needing Rapid Symptom Relief

Ketamine may be particularly helpful when rapid improvement is critical, such as in cases of severe depression with suicidal ideation. Clinical trials have shown that ketamine can reduce suicidal thoughts quickly, though ongoing monitoring remains essential.

For patients who cannot wait weeks for another medication trial to take effect, this rapid action can be life-changing.

Individuals Without Certain Contraindications

Good candidates typically do not have uncontrolled high blood pressure, active psychosis, or unstable cardiovascular disease. Because ketamine can temporarily raise blood pressure and cause dissociation, clinicians carefully evaluate medical history.

Patients with active substance use disorders may require additional assessment, as ketamine carries abuse potential outside supervised settings.

Those Willing to Participate in Structured Monitoring

Ketamine treatment is not a one-time injection given casually. It requires clinic visits, monitoring during and after administration, and follow-up care. Ideal candidates are willing to engage in structured treatment protocols and ongoing evaluation.

At Lonerock Clinic, this includes comprehensive assessments and integration into a broader mental health plan.

Who May Not Be an Ideal Candidate?

While ketamine offers hope, it is not appropriate for everyone.

Individuals with untreated psychotic disorders may face increased risk of symptom exacerbation. Those with poorly controlled hypertension or significant cardiac conditions require careful consideration or alternative approaches.

Pregnancy is generally a contraindication unless benefits clearly outweigh risks and are discussed thoroughly with medical providers.

Additionally, patients seeking ketamine solely for convenience or without prior evidence-based treatment trials may not meet criteria for treatment-resistant depression.

IV Ketamine vs. Esketamine Nasal Spray

Understanding available forms of treatment can clarify candidacy.

Intravenous Ketamine

IV ketamine is commonly administered off-label in specialized clinics. A typical protocol involves subanesthetic infusions over about 40 minutes, often given several times per week during an induction phase.

IV administration allows precise control of dosing and blood levels. Many studies demonstrating rapid antidepressant effects have used this route.

Esketamine (Spravato)

Esketamine is the S-enantiomer of ketamine and is FDA-approved for treatment-resistant depression. It is delivered as a nasal spray in certified clinics under a Risk Evaluation and Mitigation Strategy (REMS) program.

Patients must remain under observation for at least two hours after dosing. Esketamine is typically prescribed alongside an oral antidepressant.

Choice of approach depends on patient preference, insurance coverage, medical history, and provider expertise.

What to Expect During Treatment

Understanding the process can reduce anxiety about starting therapy.

Initial Evaluation

Before beginning ketamine for treatment resistant depression, patients undergo a comprehensive psychiatric and medical evaluation. This includes reviewing past treatments, assessing current symptoms, and screening for contraindications.

Standardized scales may be used to measure baseline severity.

During Administration

During IV infusion or intranasal dosing, patients may experience dissociation, altered perception, or mild dizziness. These effects are generally temporary and monitored closely.

Vital signs are tracked throughout the session.

After Treatment

Patients remain under observation until acute effects resolve. Some report immediate mood lifting, while others notice gradual changes over the next 24 to 72 hours.

Repeated sessions are often necessary to sustain benefit.

Benefits and Limitations

Ketamine’s primary advantage is speed. For many individuals, symptom reduction occurs far more quickly than with standard antidepressants.

However, durability remains a challenge. Benefits may diminish within days or weeks without maintenance treatment. Long-term data is still evolving, and ongoing discussion about risks and benefits is essential.

Side effects are typically transient but can include dissociation, nausea, and elevated blood pressure. Rare concerns about cognitive effects or bladder issues are mostly associated with high-dose recreational use rather than clinical protocols.

Integrating Ketamine Into Whole-Person Care

Ketamine should not stand alone. Combining treatment with psychotherapy, lifestyle changes, and coordinated primary care can enhance outcomes.

At Lonerock Clinic, the emphasis on integrated healthcare means addressing mental health alongside physical wellness. Hormone balance, chronic condition management, and supportive therapy all contribute to sustainable improvement.

For many patients, ketamine serves as a catalyst—lifting the heaviest symptoms so they can more fully engage in therapy and life changes.

Frequently Asked Questions

Is ketamine for treatment resistant depression safe?

When administered in a controlled medical setting with proper screening and monitoring, ketamine is generally considered safe. Temporary side effects are common but usually resolve within hours. Ongoing evaluation reduces risk.

How quickly does ketamine work?

Some patients notice improvement within hours, while others experience changes within a few days. Rapid reduction in suicidal thoughts has been observed in clinical studies, though individual responses vary.

How long do the benefits last?

After a single treatment, benefits may last days to weeks. Maintenance sessions are often needed to sustain improvement. Long-term treatment plans are individualized.

Will insurance cover ketamine therapy?

Esketamine is more likely to be covered by insurance due to FDA approval. IV ketamine coverage varies. Patients should consult their insurance provider and clinic billing team for specific information.

A New Path Forward at Lonerock Clinic

Living with depression that does not respond to standard treatments can feel isolating and discouraging. You may have started to believe that lasting relief is out of reach. But advances in neuroscience are opening new doors.

Ketamine for treatment resistant depression is not a miracle cure, and it is not for everyone. Yet for carefully screened patients, it offers something many have not felt in years: rapid, tangible change. At Lonerock Clinic, compassionate providers take the time to evaluate whether this therapy fits your unique medical and emotional needs.

Whole-person care means listening to your story, reviewing your history, and creating a treatment plan that aligns with your goals. If you are struggling despite multiple treatment attempts, you do not have to navigate this alone.

Reach out to Lonerock Clinic to schedule a consultation and explore whether ketamine therapy could be part of your path toward healing. When the weight of depression feels unmovable, the right support can help you begin to breathe again.